Oslo Cancer Cluster is happy to receive the status as a Mature Cluster in the Norwegian Innovation Clusters programme.
Patients report their own symptoms in a new project at Ahus, in which the university hospital collaborates with Roche and Kaiku Health.
Ultimovacs announces a new clinical study in lung cancer.
Eli Lilly & Company is now part of the national Norwegian IMPRESS study.
Statsbudsjettet for 2022 inneholder lite for kreftpasienter og innovasjon innen kreftbehandling.
Did you know that Oslo Cancer Cluster is a changemaker?